Literature DB >> 12445646

Characterization of outer membrane efflux proteins OpmE, OpmD and OpmB of Pseudomonas aeruginosa: molecular cloning and development of specific antisera.

Takeshi Murata1, Naomasa Gotoh, Takeshi Nishino.   

Abstract

The third genes, opmE, opmD and opmB, of multidrug efflux operons deduced from the Pseudomonas aeruginosa PAO1 genome data were cloned by polymerase chain reaction. The opmB gene product showed functional cooperation with inner membrane-associated components, MexAB, MexCD and MexXY, of the previously characterized multidrug efflux systems responsible for resistance to antimicrobial agents and extrusion of ethidium. The opmE and opmD gene products did not show functional cooperation. Immunoblots using a specific rabbit antiserum demonstrated, through exponential to stationary phases, constant expression of opmB and growth phase-dependent expression of opmD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12445646     DOI: 10.1111/j.1574-6968.2002.tb11456.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  14 in total

1.  Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously.

Authors:  Catherine Llanes; Didier Hocquet; Christelle Vogne; Dounia Benali-Baitich; Catherine Neuwirth; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

2.  Substrate-dependent utilization of OprM or OpmH by the Pseudomonas aeruginosa MexJK efflux pump.

Authors:  Rungtip Chuanchuen; Takeshi Murata; Naomasa Gotoh; Herbert P Schweizer
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

Review 3.  The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.

Authors:  Xian-Zhi Li; Patrick Plésiat; Hiroshi Nikaido
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

4.  Pseudomonas aeruginosa SoxR does not conform to the archetypal paradigm for SoxR-dependent regulation of the bacterial oxidative stress adaptive response.

Authors:  Marco Palma; Juan Zurita; Julian A Ferreras; Stefan Worgall; Davise H Larone; Lei Shi; Fabien Campagne; Luis E N Quadri
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis.

Authors:  Christelle Vogne; Julio Ramos Aires; Christiane Bailly; Didier Hocquet; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

6.  Negative regulation of quorum-sensing systems in Pseudomonas aeruginosa by ATP-dependent Lon protease.

Authors:  Akiko Takaya; Fumiaki Tabuchi; Hiroko Tsuchiya; Emiko Isogai; Tomoko Yamamoto
Journal:  J Bacteriol       Date:  2008-04-11       Impact factor: 3.490

Review 7.  Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Authors:  Philip D Lister; Daniel J Wolter; Nancy D Hanson
Journal:  Clin Microbiol Rev       Date:  2009-10       Impact factor: 26.132

8.  Interaction of ArmZ with the DNA-binding domain of MexZ induces expression of mexXY multidrug efflux pump genes and antimicrobial resistance in Pseudomonas aeruginosa.

Authors:  Adam Kawalek; Magdalena Modrzejewska; Bartlomiej Zieniuk; Aneta Agnieszka Bartosik; Grazyna Jagura-Burdzy
Journal:  Antimicrob Agents Chemother       Date:  2019-09-16       Impact factor: 5.191

9.  Role of OmpA in the multidrug resistance phenotype of Acinetobacter baumannii.

Authors:  Younes Smani; Anna Fàbrega; Ignasi Roca; Viviana Sánchez-Encinales; Jordi Vila; Jerónimo Pachón
Journal:  Antimicrob Agents Chemother       Date:  2013-12-30       Impact factor: 5.191

10.  MexXY multidrug efflux system of Pseudomonas aeruginosa.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2012-11-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.